Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 26, 2025

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

134 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6919
Caliway Biopharmaceuticals
NT$184.501.4%211.1%NT$286.2bNT$245.00PS6383xE199.6%n/a
1762
Chunghwa Chemical Synthesis & Biotech
NT$26.001.8%-39.1%NT$2.0bNT$28.00PS1.7xE116.8%0.7%
6446
PharmaEssentia
NT$512.000.2%-10.1%NT$189.4bNT$592.01PE46.7xE70.2%0.2%
1789
ScinoPharm Taiwan
NT$18.902.7%-25.7%NT$14.9bNT$18.00PE73xE31.4%1.9%
1795
Lotus Pharmaceutical
NT$255.0034.6%-5.6%NT$67.1bNT$378.20PE13.8xE28.6%2.2%
6712
Ever Supreme Bio Technology
NT$178.508.8%5.6%NT$15.6bNT$210.00PE38.3xE18.2%2.6%
6472
Bora Pharmaceuticals
NT$680.00-1.4%7.8%NT$84.4bNT$872.67PE16.5xE8.3%1.7%
4162
PharmaEngine
NT$66.200.6%-24.6%NT$9.5bn/aPE5.8xE-88.4%9.1%
1760
Panion & Bf Biotech
NT$69.40-0.9%-23.3%NT$6.0bn/aPE47xn/a2.6%
4168
GlycoNex Incorporation
NT$25.25-0.4%-1.9%NT$2.7bn/aPS78.1xn/a0%
8279
Syngen BiotechLtd
NT$123.50-1.2%-6.4%NT$3.3bn/aPE12xn/a4.0%
6580
TaiRx
NT$27.501.1%-17.3%NT$3.0bn/aPS196.9xn/an/a
6885
BRIM Biotechnology
NT$31.750.5%-31.7%NT$4.2bn/aPS2091xn/an/a
6492
Senhwa Biosciences
NT$41.303.5%-24.5%NT$3.7bn/aPS3683.4xn/an/a
4170
Vectorite Biomedical
NT$12.60-6.7%-16.0%NT$551.5mn/aPS8.1xn/an/a
4111
Chi Sheng Pharma & Biotech
NT$30.30-0.2%21.0%NT$1.8bn/aPE12.9xn/a3.1%
1799
Easywell Biomedicals
NT$46.203.1%-61.5%NT$5.8bn/aPS9.5xn/an/a
6814
Lukas Biomedical
NT$26.801.7%-11.3%NT$1.1bn/aPS6.2xn/an/a
6677
Anxo Pharmaceutical
NT$22.00-3.5%-35.4%NT$1.2bn/aPS1.4xn/a1.8%
6892
Taiwan Bio Therapeutics
NT$28.05-0.5%-33.2%NT$2.4bn/an/an/an/a
6748
ACRO Biomedical
NT$72.901.1%185.9%NT$4.5bn/aPS122.3xn/an/a
6610
TWi Biotechnology
NT$36.7018.6%169.9%NT$3.9bn/aPB14.7xn/an/a
6875
Pharmosa Biopharm
NT$46.00-0.1%-27.0%NT$5.9bn/aPS34.2xn/an/a
4160
Genetics Generation Advancement
NT$54.201.7%-40.8%NT$1.4bn/aPE45.1xn/a3.4%
Page 1 of 6